C12N 9/0069
Acting on single donors with incorporation of molecular oxygen, i.e. oxygenases
Official title: {acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)}
C12N9/0069 (Acting on single donors with incorporation of molecular oxygen, i.e. oxygenases) appears on 806 US grants and 1,121 published applications in this corpus.
Search patents in C12N- Granted patents
- 806
- Published applications
- 1,121
- Assignees
- 496
- Inventors
- 2,196
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 7 | 0 |
| 1994 | 6 | 0 |
| 1995 | 7 | 0 |
| 1996 | 18 | 0 |
| 1997 | 23 | 0 |
| 1998 | 21 | 0 |
| 1999 | 10 | 0 |
| 2000 | 18 | 0 |
| 2001 | 24 | 4 |
| 2002 | 21 | 14 |
| 2003 | 18 | 46 |
| 2004 | 14 | 27 |
| 2005 | 14 | 24 |
| 2006 | 14 | 28 |
| 2007 | 21 | 19 |
| 2008 | 13 | 26 |
| 2009 | 7 | 33 |
| 2010 | 15 | 23 |
| 2011 | 15 | 32 |
| 2012 | 16 | 46 |
| 2013 | 24 | 45 |
| 2014 | 32 | 75 |
| 2015 | 44 | 57 |
| 2016 | 51 | 56 |
| 2017 | 36 | 63 |
| 2018 | 35 | 57 |
| 2019 | 54 | 77 |
| 2020 | 43 | 54 |
| 2021 | 34 | 47 |
| 2022 | 35 | 64 |
| 2023 | 31 | 51 |
| 2024 | 26 | 52 |
| 2025 | 30 | 53 |
| 2026 | 20 | 48 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Luciferase linked immunosorbent assay6 Oct 2026US 12,753,245 B2Institut Pasteur
- Cleaning composition comprising an engineered fatty acid alpha-dioxygenase15 Sep 2026US 12,735,658 B2The Procter & Gamble Company
- Methods for the evaluation of neutralizing antibodies for adeno-associated virus7 Jul 2026US 12,674,178 B2Regents of the University of Minnesota
- Pathogen detection method and apparatus7 Jul 2026US 12,674,798 B2Industry-Academic Cooperation Foundation, Yeungnam University
- Lipids and lipid nanoparticle formulations for delivery of nucleic acids30 Jun 2026US 12,667,627 B2Acuitas Therapeutics, Inc.
- Genetically engineered cd4 t-cells for in situ synthesis of proteins8 Oct 2026US 2026/0308515 A1SRI International
- Photoswitch protein8 Oct 2026US 2026/0308556 A1Kanagawa Institute of Industrial Science and Technology
- Fully genetically encoded nad+protein probe based on resonance energy transfer,and preparation method therefor and use thereof17 Sep 2026US 2026/0275323 A1Shenzhen Institutes of Advanced Technology
- Methods for producing modified betalains in yeast3 Sep 2026US 2026/0258343 A1Danmarks Tekniske Universitet
- Engineered Luciferases and Luciferin Substrates27 Aug 2026US 2026/0250737 A1Monod Bio, Inc.
Most cited
By later US patents
- Delivery of exogenous DNA sequences in a mammal1,218US 5,580,859 AVical Incorporated · 1996
- Methods and materials for making and using transgenic dicamba-degrading organisms1,215US 8,629,323 B2Board of Regents of the University of Nebraska · 2014
- Methods and materials for making and using transgenic dicamba-degrading organisms1,214US 7,812,224 B2Board of Regents of the University of Nebraska · 2010
- Methods and materials for making and using transgenic dicamba-degrading organisms1,208US 8,119,380 B2Board of Regents of the University of Nebraska · 2012
- Modified DMO enzyme and methods of its use1,142US 7,884,262 B2Monsanto Technology LLC · 2011